Jane Street’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Jane Street’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-26,858	Closed	-$7.55K	–	10991
2024 Q3	$7.55K	Sell	26,858 -66,131	-71%	-$30.9K	﹤0.01%	9375
2024 Q2	$69.7K	Buy	+92,989	New	+$59.5K	﹤0.01%	8846
2024 Q1	–	Sell	-16,132	Closed	-$13.2K	–	10452
2023 Q4	$13.2K	Buy	16,132 +10,858	+206%	+$22.1K	﹤0.01%	8949
2023 Q3	$15.7K	Buy	+5,274	New	+$9.63K	﹤0.01%	8331

Other funds holding NVOS

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Jane Street's NVOS Position: Q4 2024 in Review

Jane Street sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 26,858 shares — an estimated $7.55K sold.

Jane Street first reported a position in NVOS in Q3 2023 and held it in 4 quarters. The position peaked at $69.7K in Q2 2024. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

Jane Street reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Jane Street sold 26,858 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $7.55K.
Jane Street first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
Jane Street's Novo Integrated Sciences, Inc. Common Stock position peaked at $69.7K in Q2 2024.
1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.